Semaglutide and tirzepatide are the two medication families in the Avono weight management program. Both are available through Avono as compounded medications, by prescription only.
One receptor or two
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on two receptors, GIP and GLP-1. Both hormones are involved in appetite and blood sugar regulation.
Choosing is a clinical decision
Which medication, if either, is appropriate depends on your health history and goals. Your licensed clinician makes that decision during review.
Comparing GLP-1 options? See semaglutide and tirzepatide programs and current prices.